Stereochemistry in compound registration
Table of contents Flat bonds OR structure wedge types OR structure replicates Multiple OR labels…
CertaraAugust 14, 2022
Why are human radiolabeled mass-balance studies important in clinical pharmacology & drug development?
Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…
CertaraAugust 5, 2022
Mind-blowing applications of QSP in drug development: Part 1
R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…
CertaraAugust 4, 2022
Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction.
Find out how Liver dysfunction increases nalbuphine half‑life and Vd; PK analysed using Phoenix WinNonlin.
CertaraJuly 26, 2022
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World Patients
Explore how model predicts population‑level target attainment but large individual variability using Phoenix NLME.
CertaraJuly 25, 2022
Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial.
Discover how itraconazole markedly increases SHR2554 exposure; PK interaction assessed using Phoenix WinNonlin.
CertaraJuly 16, 2022
Simcyp® Discovery Simulator
Tailored for discovery and translational scientists, Simcyp® Discovery Simulator is an intuitive software that delivers…
CertaraJuly 14, 2022
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J.— July 12, 2022-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…
CertaraJuly 12, 2022
